Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

TNDM Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 18, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Tandem Diabetes Care Inc (TNDM)

Based on 30 analysts giving stock ratings to Tandem Diabetes Care Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
20
Buy
30
Hold
50
Sell
0
Strong Sell
0
Tandem Diabetes Care Inc

Tandem Diabetes Care Inc. Stock Analysis TNDM

United States Health Care Small Cap Report:
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is headquartered in San Diego, California and currently employs 2,500 full-time employees. The company went IPO on 2013-11-13. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Read More

Tandem Diabetes Care Inc (TNDM) Chart

Key Statistics of Tandem Diabetes Care Inc (TNDM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$13.95$14.49

Today's Open

$14.17

Volume

3.18M

P/E Ratio (TTM)

-

52 Week Range

$9.98$29.65

Market Cap

1.08B

Avg. Volume

2.53M

Dividend Yield

-

Financial Metrics & Statements of Tandem Diabetes Care Inc (TNDM)

FAQ's for Tandem Diabetes Care Inc (TNDM)

  • According to Musaffa’s Shariah screening methodology, Tandem Diabetes Care Inc (TNDM) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Tandem Diabetes Care Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Tandem Diabetes Care Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Tandem Diabetes Care Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Tandem Diabetes Care Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Tandem Diabetes Care Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.